Variantyx Company

Variantyx, a leader in high complexity hereditary disease testing, launched Genomic Unity® Prenatal Analysis test for high-risk pregnancies, entering women’s health market.
Industry: Pregnancy & Nursing
Headquarters: Framingham, Massachusetts, United States
Founded Date: 01-01-2014
Employees Number: 11-50
Funding Status: Late Stage Venture
Investors Number: 10
Total Funding: $100,500,000
Estimated Revenue: $1M to $10M
Last Funding Date: 2022-10-18
Last Funding Type: Debt Financing

Visit Website
Register and Claim Ownership